Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry

Authors:

Abstract
No abstract available
Funding Information
  • Novo Nordisk
  • AstraZeneca

This publication has 27 references indexed in Scilit: